We are live on ! Find out more

Drug Manufacturers - Specialty & Generic
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
PAHC icon
26
Phibro Animal Health
PAHC
$1.43B
$1.43B $35.24 3.53%
XERS icon
27
Xeris Biopharma Holdings
XERS
$1.42B
$1.42B $8.21 1.32%
PRGO icon
28
Perrigo
PRGO
$1.4B
$1.4B $10.14 0.5%
HROW icon
29
Harrow
HROW
$1.4B
$1.4B $37.46 2.57%
ETON icon
30
Eton Pharmaceutcials
ETON
$1.16B
$1.16B $42.31 0.66%
COLL icon
31
Collegium Pharmaceutical
COLL
$1.15B
$1.15B $35.52 0.91%
CRON
32
Cronos Group
CRON
$1.07B
$1.07B $2.86 1.78%
ALVO icon
33
Alvotech
ALVO
$1.04B
$1.04B $3.08 0.65%
PCRX icon
34
Pacira BioSciences
PCRX
$1.04B
$1.04B $26.47 2.28%
BIOA
35
BioAge Labs
BIOA
$928M
$928M $20.88 4.09%
GLAS
36
Glass House Brands
GLAS
$908M
$908M $10.12 1%
AMPH icon
37
Amphastar Pharmaceuticals
AMPH
$846M
$846M $19.18 2.46%
EVO icon
38
Evotec
EVO
$682M
$682M $1.92 1.03%
IRWD icon
39
Ironwood Pharmaceuticals
IRWD
$644M
$644M $3.91 5.39%
TLRY icon
40
Tilray
TLRY
$498M
$498M $4.03 3.87%
AQST icon
41
Aquestive Therapeutics
AQST
$468M
$468M $3.73 1.36%
EOLS icon
42
Evolus
EOLS
$407M
$407M $6.18 3.34%
KMDA icon
43
Kamada
KMDA
$403M
$403M $6.99 0.99%
CGC
44
Canopy Growth
CGC
$390M
$390M $0.9243 4.02%
EBS icon
45
Emergent Biosolutions
EBS
$378M
$378M $7.33 0.96%
AKBA icon
46
Akebia Therapeutics
AKBA
$343M
$343M $1.28 4.92%
ORGO icon
47
Organogenesis Holdings
ORGO
$328M
$328M $2.55 6.69%
TKNO icon
48
Alpha Teknova
TKNO
$260M
$260M $4.85 2.41%
SIGA icon
49
SIGA Technologies
SIGA
$222M
$222M $3.10 0.32%
ANIK icon
50
Anika Therapeutics
ANIK
$200M
$200M $15.02 0.47%
1
2
3 4

Drug Manufacturers - Specialty & Generic Stocks at a Glance

Specialty and generic drug manufacturers develop branded niche therapies, off-patent generics, and animal-health and cannabis products. Generics compete on price and manufacturing scale, while specialty brands carry pharma-like margins on smaller markets.

There are 83 Drug Manufacturers - Specialty & Generic industry stocks tracked by Wall St. Rank, worth a combined $341B.

The largest by market cap are Takeda Pharmaceutical (TAK) at $55.7B, Haleon (HLN) at $43.8B and Teva Pharmaceuticals (TEVA) at $36.2B.

Among institutional investors, Amneal Pharmaceuticals (AMRX) drew the most net new fund positions in Q1 2026: 80 funds opened new positions, taking total fund holders up 39 (14%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.